Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Change in Acquisitions & Divestments (2017 - 2025)

Standard Biotools (LAB) has disclosed Change in Acquisitions & Divestments for 14 consecutive years, with $54.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Change in Acquisitions & Divestments rose 8.0% to $54.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $214.0 million, a 32.06% decrease, with the full-year FY2024 number at $349.0 million, up 195.85% from a year prior.
  • Change in Acquisitions & Divestments was $54.0 million for Q3 2025 at Standard Biotools, up from $48.0 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $127.0 million in Q2 2024 to a low of $12.0 million in Q3 2022.
  • A 4-year average of $56.2 million and a median of $50.5 million in 2023 define the central range for Change in Acquisitions & Divestments.
  • Peak YoY movement for Change in Acquisitions & Divestments: soared 210.03% in 2024, then tumbled 62.2% in 2025.
  • Standard Biotools' Change in Acquisitions & Divestments stood at $41.0 million in 2022, then plummeted by 36.59% to $26.0 million in 2023, then skyrocketed by 130.77% to $60.0 million in 2024, then decreased by 10.0% to $54.0 million in 2025.
  • Per Business Quant, the three most recent readings for LAB's Change in Acquisitions & Divestments are $54.0 million (Q3 2025), $48.0 million (Q2 2025), and $52.0 million (Q1 2025).